Book description
Practical Utility of Biomarkers in Drug Discovery and Development
covers all aspects of biomarker research applied to drug discovery and
development and contains state-of-the-art appraisals on the practical
utility of genomic, biochemical, and protein biomarkers. Case histories
and lessons from successful and unsuccessful applications of biomarkers
are included along with key chapters on GLP validation, safety
biomarkers and proteomics biomarkers. Regulatory agency perspectives
and initiatives both in the US and internationally are also discussed.
J. Andrew Williams, PHD, is Director of Translational Oncology at
Pfizer Oncology.
Richard Lalonde, PharmD, is Vice President and Global Head of
Clinical Pharmacology at Pfizer.
Jeffrey Koup, PharmD, is a consultant for PKPD modeling and the owner
of Lakeside PKPD, LLC.
David D. Christ, PHD, is a consultant with SNC Partners LLC.
